Advertisement

Topics

Kite Pharma Submits Investigational New Drug (IND) Application For KITE-585, Anti-BCMA CAR-T Therapy Candidate For Multiple Myeloma

20:00 EDT 7 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Kite Pharma Submits Investigational New Drug (IND) Application For KITE-585, Anti-BCMA CAR-T Therapy Candidate For Multiple Myeloma

NEXT ARTICLE

More From BioPortfolio on "Kite Pharma Submits Investigational New Drug (IND) Application For KITE-585, Anti-BCMA CAR-T Therapy Candidate For Multiple Myeloma"

Quick Search
Advertisement